DCLK1 and neoplasm: DCLK1 knockdown resulted in decreased expression of OCT4 (>30%, Figure 6C), KLF4 (>45%, Figure 6D), LIN28 (>40%, Figure 6E), and NANOG (>50%, Figure 6F) in tumor xenografts.